PRINCEPS DIVISION

Qeginus® Quetiapine Fumarate Tablets

QEGINUS® is a prescription medicine containing quetiapine fumarate. Explore its available strengths, product composition and important prescribing information for healthcare professionals.
qeginus product image

PRODUCT OVERVIEW

About Qeginus®

QEGINUS® contains quetiapine fumarate, an atypical antipsychotic medicine available in tablet strengths of 25 mg, 50 mg and 100 mg, as confirmed for this product page.

Quetiapine is a prescription medicine used in the management of certain psychiatric conditions, subject to the approved indications and prescribing information applicable to the specific product and strength.

This page provides an overview of the QEGINUS® product range, its available strengths and important safety information for healthcare professionals. Treatment decisions, dosage and monitoring must be determined by a qualified prescriber.

Medical illustration of brain activity alongside a mental healthcare consultation.

Composition & Therapeutic Profile

QEGINUS® is available in three tablet strengths to support prescribing according to the individual patient’s clinical requirements and approved prescribing information.

Pharmaceutical formulation ingredients icon

Composition

25 mg | 50 mg | 100 mg

Topical analgesic formulation icon

Therapeutic Class

A prescription medicine belonging to the atypical antipsychotic class.

Localized pain management icon

Therapeutic Focus

Product information for approved psychiatric indications, based on the applicable prescribing information.

How QEGINUS® Works

Quetiapine is an atypical antipsychotic medicine that acts on specific neurotransmitter receptors in the brain, particularly serotonin and dopamine receptors. These neurotransmitter systems are involved in regulating several aspects of brain function.

Its pharmacological activity forms the basis for its use in certain psychiatric conditions, as specified in approved prescribing information. The selection of treatment and ongoing monitoring must be guided by a qualified psychiatrist or other authorised prescriber.

Key points

Medical illustration representing brain neurotransmitter signalling and neuroscience

Clinical & Therapeutic Areas

QEGINUS® contains quetiapine fumarate, a prescription medicine used for certain psychiatric conditions. Its approved therapeutic applications depend on the specific product registration and prescribing information. The appropriate indication, treatment plan and monitoring should always be determined by a qualified healthcare professional.

Approved Indications

Approved Indications

Refer to the approved prescribing information for the specific indications applicable to QEGINUS®.

Individualised Treatment

Individualised Treatment

Treatment decisions should be based on the patient's clinical condition and professional assessment.

Ongoing Monitoring

Ongoing Monitoring

Appropriate clinical monitoring is important throughout treatment, as directed by the prescribing professional.

Frequently Asked Questions About QEGINUS®

QEGINUS® is a prescription medicine containing quetiapine fumarate, an atypical antipsychotic medicine.

QEGINUS® is available in three tablet strengths: 25 mg, 50 mg and 100 mg.

Quetiapine belongs to the atypical antipsychotic class of medicines.

Yes. QEGINUS® is a prescription medicine and should be used only under the guidance of a qualified healthcare professional.

No. Treatment should not be started, stopped or adjusted without consulting the prescribing healthcare professional.

Discover Our Specialty Pharmaceutical Portfolio

Explore the MERGA and PRINCEPS divisions of Seginus Pharma and discover our portfolio of pharmaceutical products across key therapeutic areas.